triethylammonium cation has been researched along with warfarin in 1 studies
Studies (triethylammonium cation) | Trials (triethylammonium cation) | Recent Studies (post-2010) (triethylammonium cation) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
25 | 0 | 10 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | triethylammonium cation (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fodor, G; Ilisz, I; Péter, A; Szemán, J; Szente, L; Varga, G; Visy, J | 1 |
1 other study(ies) available for triethylammonium cation and warfarin
Article | Year |
---|---|
Comparison of separation performances of novel β-cyclodextrin-based chiral stationary phases in high-performance liquid chromatographic enantioseparation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Buffers; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Coumarins; Cyclodextrins; Dansyl Compounds; Humans; Hydrogen-Ion Concentration; Isomerism; Methanol; Molecular Structure; Propionates; Quaternary Ammonium Compounds; Solvents | 2012 |